Bandingkan Harga & Kinerja Fore Kopi Indonesia Tbk. (FORE) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fore Kopi Indonesia Tbk. dan UBC Medical Indonesia Tbk.: Fore Kopi Indonesia Tbk. diperdagangkan di Rp615 (kapitalisasi pasar 5,44 T, volume 24 jam 1,89 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Fore Kopi Indonesia Tbk. jauh lebih besar — sekitar 9,3× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Fore Kopi Indonesia Tbk. lebih aktif diperdagangkan (1,89 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FORE | LABS | |
|---|---|---|
Kapitalisasi Pasar | 5,44 T | 584,6 M |
Volume | 1,89 jt | 817,3 rb |
Lot | 18,9 rb | 8,17 rb |
Perputaran | 1,15 M | 120,01 jt |
Harga Rata-rata | 609,92 | 146,84 |
Nilai Transaksi | 1,15 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 615 | 146 |
Volume Ekuilibrium Indikatif | 1,29 rb | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fore Kopi Indonesia Tbk.
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Selengkapnya di halaman FORE →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
